Back to Search
Start Over
Assessment of Residual Cancer Burden and Event-Free Survival in Neoadjuvant Treatment for High-risk Breast Cancer: An Analysis of Data From the I-SPY2 Randomized Clinical Trial.
- Source :
- JAMA Oncology; Nov2021, Vol. 7 Issue 11, p1654-1663, 10p
- Publication Year :
- 2021
Details
- Language :
- English
- ISSN :
- 23742437
- Volume :
- 7
- Issue :
- 11
- Database :
- Complementary Index
- Journal :
- JAMA Oncology
- Publication Type :
- Academic Journal
- Accession number :
- 153687887
- Full Text :
- https://doi.org/10.1001/jamaoncol.2021.3690